HEADER RAR-RELATED ORPHAN RECEPTOR-G (RORG) 23-MAR-17 5NI8 TITLE LIGAND COMPLEX OF RORG LBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 6 ORPHAN RECEPTOR-GAMMA; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: THE TETHERED SRC2-2 PEPTIDE; COMPND 10 CHAIN: C; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RAR-RELATED ORPHAN RECEPTOR-G (RORG), TRANSCRIPTION, RORG LIGAND, KEYWDS 2 STRUCTURE-BASED DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,F.NARJES REVDAT 3 17-JAN-24 5NI8 1 LINK REVDAT 2 24-OCT-18 5NI8 1 JRNL REVDAT 1 22-AUG-18 5NI8 0 JRNL AUTH F.NARJES,Y.XUE,S.VON BERG,J.MALMBERG,A.LLINAS,R.I.OLSSON, JRNL AUTH 2 J.JIRHOLT,H.GRINDEBACKE,A.LEFFLER,N.HOSSAIN,M.LEPISTO, JRNL AUTH 3 L.THUNBERG,H.LEEK,A.AAGAARD,J.MCPHEAT,E.L.HANSSON,E.BACK, JRNL AUTH 4 S.TANGEFJORD,R.CHEN,Y.XIONG,G.HONGBIN,T.G.HANSSON JRNL TITL POTENT AND ORALLY BIOAVAILABLE INVERSE AGONISTS OF ROR GAMMA JRNL TITL 2 T RESULTING FROM STRUCTURE-BASED DESIGN. JRNL REF J. MED. CHEM. V. 61 7796 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30095900 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00783 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 PACIOREK REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 23269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1190 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2727 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2821 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2571 REMARK 3 BIN R VALUE (WORKING SET) : 0.2831 REMARK 3 BIN FREE R VALUE : 0.2663 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.72 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2140 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 177 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.11120 REMARK 3 B22 (A**2) : -4.11120 REMARK 3 B33 (A**2) : 8.22250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.353 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.204 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.168 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.190 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.162 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.916 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2222 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2991 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 801 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 333 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2222 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 2 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 268 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2604 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.57 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NI8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200004178. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.984 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23286 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 48.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.23800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.10 REMARK 200 R MERGE FOR SHELL (I) : 1.41700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3L0L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS TRIS PH 6.25, 0.1 M NACL, 2M REMARK 280 NAFORMATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.15500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.07500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.07500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.57750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.07500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.07500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 118.73250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.07500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.07500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.57750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.07500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.07500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 118.73250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 79.15500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 243 REMARK 465 HIS A 244 REMARK 465 ASN A 245 REMARK 465 HIS A 246 REMARK 465 ASN A 247 REMARK 465 HIS A 248 REMARK 465 ASN A 249 REMARK 465 HIS A 250 REMARK 465 ASN A 251 REMARK 465 HIS A 252 REMARK 465 ASN A 253 REMARK 465 HIS A 254 REMARK 465 ASN A 255 REMARK 465 GLY A 256 REMARK 465 GLY A 257 REMARK 465 SER A 510 REMARK 465 GLY A 511 REMARK 465 GLY A 512 REMARK 465 SER A 513 REMARK 465 GLY A 514 REMARK 465 GLY A 515 REMARK 465 LYS A 516 REMARK 465 GLU A 517 REMARK 465 LYS A 518 REMARK 465 HIS A 519 REMARK 465 LYS A 520 REMARK 465 ILE A 521 REMARK 465 LEU A 522 REMARK 465 HIS A 523 REMARK 465 ARG A 524 REMARK 465 LEU A 525 REMARK 465 LEU A 526 REMARK 465 GLN A 527 REMARK 465 ASP A 528 REMARK 465 SER A 529 REMARK 465 SER A 530 REMARK 465 LYS C 684 REMARK 465 GLU C 685 REMARK 465 LYS C 686 REMARK 465 HIS C 687 REMARK 465 SER C 698 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 285 1.68 -69.68 REMARK 500 GLN A 286 -70.36 70.49 REMARK 500 CYS A 393 50.65 -141.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 602 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 366 O REMARK 620 2 TYR A 369 O 99.5 REMARK 620 3 SER A 408 OG 96.5 108.4 REMARK 620 4 HOH A 755 O 173.3 74.6 88.5 REMARK 620 5 HOH A 768 O 88.3 93.5 156.4 88.9 REMARK 620 6 HOH A 831 O 74.7 163.2 88.1 110.1 70.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8Y2 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 602 DBREF 5NI8 A 265 507 UNP P51449 RORG_HUMAN 265 507 DBREF 5NI8 C 684 698 PDB 5NI8 5NI8 684 698 SEQADV 5NI8 MET A 243 UNP P51449 INITIATING METHIONINE SEQADV 5NI8 HIS A 244 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 245 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 246 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 247 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 249 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 251 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 253 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 254 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 255 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 257 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLU A 258 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASN A 259 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LEU A 260 UNP P51449 EXPRESSION TAG SEQADV 5NI8 TYR A 261 UNP P51449 EXPRESSION TAG SEQADV 5NI8 PHE A 262 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLN A 263 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 264 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 508 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 509 UNP P51449 EXPRESSION TAG SEQADV 5NI8 SER A 510 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 511 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 512 UNP P51449 EXPRESSION TAG SEQADV 5NI8 SER A 513 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 514 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLY A 515 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LYS A 516 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLU A 517 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LYS A 518 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 519 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LYS A 520 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ILE A 521 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LEU A 522 UNP P51449 EXPRESSION TAG SEQADV 5NI8 HIS A 523 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ARG A 524 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LEU A 525 UNP P51449 EXPRESSION TAG SEQADV 5NI8 LEU A 526 UNP P51449 EXPRESSION TAG SEQADV 5NI8 GLN A 527 UNP P51449 EXPRESSION TAG SEQADV 5NI8 ASP A 528 UNP P51449 EXPRESSION TAG SEQADV 5NI8 SER A 529 UNP P51449 EXPRESSION TAG SEQADV 5NI8 SER A 530 UNP P51449 EXPRESSION TAG SEQRES 1 A 288 MET HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN SEQRES 2 A 288 GLY GLY GLU ASN LEU TYR PHE GLN GLY ALA SER LEU THR SEQRES 3 A 288 GLU ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR SEQRES 4 A 288 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 5 A 288 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 6 A 288 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 7 A 288 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 8 A 288 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN SEQRES 9 A 288 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 10 A 288 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 11 A 288 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 12 A 288 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 13 A 288 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 14 A 288 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 15 A 288 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 16 A 288 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 17 A 288 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 18 A 288 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 19 A 288 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 20 A 288 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 21 A 288 LYS GLU LEU PHE SER GLY GLY SER GLY GLY SER GLY GLY SEQRES 22 A 288 LYS GLU LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SEQRES 23 A 288 SER SER SEQRES 1 C 15 LYS GLU LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SEQRES 2 C 15 SER SER HET 8Y2 A 601 34 HET NA A 602 1 HETNAM 8Y2 2-(4-ETHYLSULFONYLPHENYL)-~{N}-[4-(2- HETNAM 2 8Y2 PHENYLMETHOXYPYRIDIN-3-YL)THIOPHEN-2-YL]ETHANAMIDE HETNAM NA SODIUM ION FORMUL 3 8Y2 C26 H24 N2 O4 S2 FORMUL 4 NA NA 1+ FORMUL 5 HOH *177(H2 O) HELIX 1 AA1 ASN A 259 GLN A 263 5 5 HELIX 2 AA2 SER A 266 GLU A 283 1 18 HELIX 3 AA3 ARG A 288 GLN A 295 1 8 HELIX 4 AA4 ARG A 296 ASN A 298 5 3 HELIX 5 AA5 SER A 301 LYS A 311 1 11 HELIX 6 AA6 SER A 312 LEU A 338 1 27 HELIX 7 AA7 GLY A 340 LEU A 344 5 5 HELIX 8 AA8 CYS A 345 CYS A 366 1 22 HELIX 9 AA9 GLY A 384 GLY A 392 5 9 HELIX 10 AB1 CYS A 393 ALA A 409 1 17 HELIX 11 AB2 SER A 413 ILE A 426 1 14 HELIX 12 AB3 GLU A 435 THR A 457 1 23 HELIX 13 AB4 ARG A 459 LEU A 463 5 5 HELIX 14 AB5 PRO A 468 HIS A 490 1 23 HELIX 15 AB6 HIS A 490 PHE A 498 1 9 HELIX 16 AB7 PRO A 499 SER A 507 1 9 HELIX 17 AB8 ILE C 689 ASP C 696 1 8 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 LINK O CYS A 366 NA NA A 602 1555 1555 2.24 LINK O TYR A 369 NA NA A 602 1555 1555 2.24 LINK OG SER A 408 NA NA A 602 1555 1555 2.44 LINK NA NA A 602 O HOH A 755 1555 1555 2.79 LINK NA NA A 602 O HOH A 768 1555 1555 2.84 LINK NA NA A 602 O HOH A 831 1555 1555 3.06 SITE 1 AC1 14 CYS A 285 GLN A 286 LEU A 287 CYS A 320 SITE 2 AC1 14 HIS A 323 ARG A 364 ARG A 367 ALA A 368 SITE 3 AC1 14 PHE A 377 PHE A 378 PHE A 388 ILE A 397 SITE 4 AC1 14 PHE A 401 HOH A 708 SITE 1 AC2 6 CYS A 366 TYR A 369 SER A 408 HOH A 755 SITE 2 AC2 6 HOH A 768 HOH A 831 CRYST1 62.150 62.150 158.310 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016090 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016090 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006317 0.00000